Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • kicka11
    Junior Member
    • Jul 2012
    • 6

    #1

    Help needed with Nanostring data

    I have data on NanoString for samples with two different phenotypes based on gene expression profiling and GSEA: 'high' and 'low'.

    A priori we categorised cases as high or low and now tested NanoString on a 53 gene signature for 6 cases (3 previously identified as 'low', 3 previously identified as 'high'; these were tested in duplicate).

    I need advice about how I can no analyse the data. We have run normalisations (there are some issues with this) but I cannot work out how to best assess significance and fold change.

    Any advice gratefully received.
  • frcop
    Junior Member
    • Feb 2011
    • 6

    #2
    Nanostring/nCounter analysis

    Nanostring / nCounter data are in the end just counts. So you can use methods that have been developed for RNA-seq counts to analyse these data (e.g. edgeR and DESeq in R/BioConductor). However, you can't use the normalisation procedure of these methods. You need to replace the normalisation values by values you have calculated yourself (first you correct using the positive probes and negative spiked-in probes and next you use normalisation genes included in your probeset). After you replaced the normalisation values, you can proceed with the analysis as described for RNA-seq.

    This depends off course on the quality of your normalisation probes, you can select a subset using e.g. geNorm, a tool developed for qPCR analysis.

    Comment

    • kicka11
      Junior Member
      • Jul 2012
      • 6

      #3
      Housekeeper help

      Thanks that's really useful.

      The housekeepers we have used seem to be MYC influenced (GAPDH, TUBB, ACTB). Any ideas for genes that may not be so susceptible to MYC (but that would hopefully also have similar expression across B cell lymphoma subtypes)? Am I asking for too much??
      Last edited by kicka11; 09-07-2012, 11:27 AM. Reason: .

      Comment

      • frcop
        Junior Member
        • Feb 2011
        • 6

        #4
        Housekeeping gene selection

        I'm working on plants, so I'm not an expert on these cell types. Based on the names, I can deduce that the genes you list are 'standard' housekeeping genes. While these should work in most cases, this apparently is not the case for you.

        The only advice I can give you is to try to select stable genes based on e.g. microarray or RNA-seq data of the cell types (and conditions) you're interested in. Perhaps you're lucky and some or in your nCounter set?

        Comment

        • kicka11
          Junior Member
          • Jul 2012
          • 6

          #5
          No luck so far

          Thanks again. Unfortunately no there were no suitable genes in the restricted NanoString set but we are looking back at some similar tissue types which have been previously assessed on the Affymetrix platform.

          Comment

          • kshen
            Junior Member
            • Aug 2012
            • 2

            #6
            You can try nanostringnorm, which is a pretty nice R package to do the normalization for nanostring data. (http://cran.r-project.org/web/packag...orm/index.html).

            I recently worked on a pretty large nanostring data. There are some technical replicates so I was able to evaluate differential normalization procedures. My current pipeline is to use positive control /negative control /house keeping genes to do the normalization and use DEseq to identify differentially expressed genes.

            Comment

            • MortG
              Junior Member
              • Aug 2013
              • 1

              #7
              NanoStringNorm

              I have to work with NanoString data and I wanted to learn this R package called NanoStringNorm but somehow the example codes that are given, do not yield the same results as those displayed. I was wondering if I'm doing something basic very wrong or is their a discrepancy between the given code and the plots in this introductory file.

              Comment

              Latest Articles

              Collapse

              • SEQadmin2
                Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
                by SEQadmin2



                CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

                Despite this, “CRISPR helped turn genome editing from a specialized technique into
                ...
                07-31-2026, 11:01 AM
              • SEQadmin2
                Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                by SEQadmin2


                Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                The systematic characterization of the human proteome has
                ...
                07-20-2026, 11:48 AM
              • SEQadmin2
                Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                by SEQadmin2



                Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                ...
                07-09-2026, 11:10 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by SEQadmin2, Yesterday, 10:13 AM
              0 responses
              14 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-31-2026, 02:55 AM
              0 responses
              29 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-24-2026, 12:17 PM
              0 responses
              22 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-23-2026, 11:41 AM
              0 responses
              21 views
              0 reactions
              Last Post SEQadmin2  
              Working...